Skip to main content

Akebia Therapeutics Inc. Common Stock (AKBA)

About The Company

AKBA Stock Market Logo

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

IPO Year Sector Industry
2014 Health Care Biotechnology: Pharmaceutical Preparations

Akebia Therapeutics Inc. (AKBA) Latest News

Company Contact & Address (AKBA)

Corporate Headquarters Phone Website
United States
+1 617 871-2098 Official AKBA Website

AKBA Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ AKBA

Jobs & Employment at Akebia Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page View LinkedIn page for more jobs & careers info.

Related & Similar Stock Symbols

CRDL Stock Market Price & News


Cardiol Therapeutics Inc. Class A Common Shares

BRPMU Stock Market Price & News


B. Riley Principal 150 Merger Corp. Unit

AZO Stock Market Price & News


AutoZone Inc. Common Stock